Статті в журналах з теми "Immune checkpoint inhibitors (ICIs)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Immune checkpoint inhibitors (ICIs)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Farshidpour, Maham, and William Hutson. "Immune Checkpoint Inhibitors Induced Hepatotoxicity; Gastroenterologists’ Perspectives." Middle East Journal of Digestive Diseases 14, no. 2 (April 30, 2022): 244–53. http://dx.doi.org/10.34172/mejdd.2022.279.
Повний текст джерелаShiravand, Yavar, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini-Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Ken O’Byrne, and Arutha Kulasinghe. "Immune Checkpoint Inhibitors in Cancer Therapy." Current Oncology 29, no. 5 (April 24, 2022): 3044–60. http://dx.doi.org/10.3390/curroncol29050247.
Повний текст джерелаGan, Jiadi, Yihua Huang, Wenfeng Fang, and Li Zhang. "Research progress in immune checkpoint inhibitors for lung cancer in China." Therapeutic Advances in Medical Oncology 13 (January 2021): 175883592110298. http://dx.doi.org/10.1177/17588359211029826.
Повний текст джерелаMakaremi, Shima, Zahra Asadzadeh, Nima Hemmat, Amir Baghbanzadeh, Alessandro Sgambato, Farid Ghorbaninezhad, Hossein Safarpour, et al. "Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects." Biomedicines 9, no. 9 (August 24, 2021): 1075. http://dx.doi.org/10.3390/biomedicines9091075.
Повний текст джерелаMoshirfar, Majid, Noor F. Basharat, Tanner S. Seitz, Briana K. Ply, Yasmyne C. Ronquillo, and Phillip C. Hoopes. "Corneal Transplant Rejections in Patients Receiving Immune Checkpoint Inhibitors." Journal of Clinical Medicine 11, no. 19 (September 25, 2022): 5647. http://dx.doi.org/10.3390/jcm11195647.
Повний текст джерелаKwon, Hyemi, Eun Roh, Chang Ho Ahn, Hee Kyung Kim, Cheol Ryong Ku, Kyong Yeun Jung, Ju Hee Lee, et al. "Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society." Endocrinology and Metabolism 37, no. 6 (December 31, 2022): 839–50. http://dx.doi.org/10.3803/enm.2022.1627.
Повний текст джерелаNardi Agmon, Inbar, Osnat Itzhaki Ben Zadok, and Ran Kornowski. "The Potential Cardiotoxicity of Immune Checkpoint Inhibitors." Journal of Clinical Medicine 11, no. 3 (February 7, 2022): 865. http://dx.doi.org/10.3390/jcm11030865.
Повний текст джерелаHamada, Kazuyuki, Takuya Tsunoda, and Kiyoshi Yoshimura. "Emerging Immune-Monitoring System for Immune Checkpoint Inhibitors." Life 12, no. 8 (August 13, 2022): 1229. http://dx.doi.org/10.3390/life12081229.
Повний текст джерелаSun, Yining, Nan Wang, and Nuo Zhang. "Immune Checkpoint inhibitor Therapy in Various Cancers." Highlights in Science, Engineering and Technology 14 (September 29, 2022): 318–23. http://dx.doi.org/10.54097/hset.v14i.1840.
Повний текст джерелаMazloom, Anita, Nima Ghalehsari, Victor Gazivoda, Neil Nimkar, Sonal Paul, Peter Gregos, Janice Rateshwar, and Uqba Khan. "Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies." Journal of Clinical Medicine 9, no. 8 (August 6, 2020): 2533. http://dx.doi.org/10.3390/jcm9082533.
Повний текст джерелаChen, Ru, Min Zhou, and Feng Zhu. "Immune Checkpoint Inhibitors Related to Cardiotoxicity." Journal of Cardiovascular Development and Disease 9, no. 11 (November 3, 2022): 378. http://dx.doi.org/10.3390/jcdd9110378.
Повний текст джерелаGaribaldi, Matteo, Fabio Calabrò, Gioia Merlonghi, Silvia Pugliese, Marco Ceccanti, Lara Cristiano, Tommaso Tartaglione, and Antonio Petrucci. "Immune checkpoint inhibitors (ICIs)-related ocular myositis." Neuromuscular Disorders 30, no. 5 (May 2020): 420–23. http://dx.doi.org/10.1016/j.nmd.2020.02.013.
Повний текст джерелаChen, Yuxiao, Tingfeng Jian, and Yuandong Shen. "Immune Checkpoint Inhibitors in Lung Cancer." Highlights in Science, Engineering and Technology 8 (August 17, 2022): 111–20. http://dx.doi.org/10.54097/hset.v8i.1117.
Повний текст джерелаSae-Tia, Sutthichai, Jarushka Naidoo, and Seema Mehta. "Infections in patients receiving immune checkpoint inhibitors." Journal of Clinical Oncology 37, no. 8_suppl (March 10, 2019): 155. http://dx.doi.org/10.1200/jco.2019.37.8_suppl.155.
Повний текст джерелаKim, Hye Ryeon, Jung Hun Kang, Sung Hyun Kim, Seung Tae Kim, Ilhwan Kim, Young Joo Min, Seong Hoon Shin, et al. "Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors." Cancers 14, no. 14 (July 15, 2022): 3440. http://dx.doi.org/10.3390/cancers14143440.
Повний текст джерелаPicca, Alberto, Giulia Berzero, Kevin Bihan, Vincent Jachiet, Edouard Januel, Marc Coustans, Cecile Cauquil, et al. "Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors." Neurology - Neuroimmunology Neuroinflammation 8, no. 3 (February 26, 2021): e967. http://dx.doi.org/10.1212/nxi.0000000000000967.
Повний текст джерелаEconomopoulou, Panagiota, and Amanda Psyrri. "Overview and management of toxicities of immune checkpoint-blocking drugs." Forum of Clinical Oncology 7, no. 1 (March 1, 2016): 28–37. http://dx.doi.org/10.1515/fco-2016-0004.
Повний текст джерелаPirš, Boštjan, Erik Škof, Vladimir Smrkolj, and Špela Smrkolj. "Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment." Cancers 14, no. 3 (January 27, 2022): 631. http://dx.doi.org/10.3390/cancers14030631.
Повний текст джерелаWu, Zhaozhen, Pengfei Cui, Haitao Tao, Sujie Zhang, Junxun Ma, Zhefeng Liu, Jinliang Wang, et al. "The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors." Clinical Medicine Insights: Oncology 15 (January 2021): 117955492199628. http://dx.doi.org/10.1177/1179554921996288.
Повний текст джерелаTran, Linda, and Dan Theodorescu. "Determinants of Resistance to Checkpoint Inhibitors." International Journal of Molecular Sciences 21, no. 5 (February 26, 2020): 1594. http://dx.doi.org/10.3390/ijms21051594.
Повний текст джерелаKaira, Kyoichi, Hisao Imai, and Hiroshi Kagamu. "Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma." Cancers 13, no. 5 (March 3, 2021): 1065. http://dx.doi.org/10.3390/cancers13051065.
Повний текст джерелаMaiorano, Brigida Anna, Ugo De Giorgi, Davide Ciardiello, Giovanni Schinzari, Antonio Cisternino, Giampaolo Tortora, and Evaristo Maiello. "Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day." Biomedicines 10, no. 2 (February 9, 2022): 411. http://dx.doi.org/10.3390/biomedicines10020411.
Повний текст джерелаLongo, Brunetti, Gnoni, Licchetta, Delcuratolo, Memeo, Solimando, and Argentiero. "Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma." Medicina 55, no. 10 (October 17, 2019): 698. http://dx.doi.org/10.3390/medicina55100698.
Повний текст джерелаChen, Xinru, Zhonghan Zhang, Xue Hou, Yaxiong Zhang, Ting Zhou, Jiaqing Liu, Zhihuan Lin, et al. "Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysis." Journal for ImmunoTherapy of Cancer 8, no. 2 (August 2020): e001170. http://dx.doi.org/10.1136/jitc-2020-001170.
Повний текст джерелаHoussiau, Hélène, and Emmanuel Seront. "The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma." Cancers 14, no. 7 (March 24, 2022): 1640. http://dx.doi.org/10.3390/cancers14071640.
Повний текст джерелаAl Nuhait, Mohammed, Eshtyag Bajnaid, Abdulmalik Al Otaibi, Abdullah Al Shammari, and Yousef Al Awlah. "Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia." Science Progress 104, no. 1 (January 2021): 003685042199730. http://dx.doi.org/10.1177/0036850421997302.
Повний текст джерелаMukherjee, Sarbajit, Kanak Parmar, and Elizabeth Smyth. "Immune checkpoint inhibitors in resectable gastroesophageal cancers - a review." Therapeutic Advances in Medical Oncology 14 (January 2022): 175883592211396. http://dx.doi.org/10.1177/17588359221139625.
Повний текст джерелаFong, Pak Yui, Shing Chuen Chow, Bernard Ming Hong Kwong, Charlene Cheuk Lam Lau, Christy Yik Ching Lau, Athena Hoi Ting Lee, Ha Ying Nip, Cheuk Yin Wong, Benedict Tsz Hin Yan, and Ho Yin Chung. "Management of Immune Checkpoint Inhibitor-Related Rheumatological Toxicities." Journal of Clinical Rheumatology and Immunology 20, no. 01 (May 8, 2020): 25–34. http://dx.doi.org/10.1142/s2661341720300013.
Повний текст джерелаSiefker-Radtke, Arlene O. "New Settings for Immune Checkpoint Inhibitors in Urothelial Cancer." Journal of the National Comprehensive Cancer Network 19, no. 5.5 (May 2021): 629–32. http://dx.doi.org/10.6004/jnccn.2021.5007.
Повний текст джерелаXia, Shuang, Hui Gong, Yichang Zhao, Lin Guo, Yikun Wang, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, and Miao Yan. "Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study." Cancers 15, no. 1 (December 30, 2022): 240. http://dx.doi.org/10.3390/cancers15010240.
Повний текст джерелаOnoi, Keisuke, Yusuke Chihara, Junji Uchino, Takayuki Shimamoto, Yoshie Morimoto, Masahiro Iwasaku, Yoshiko Kaneko, Tadaaki Yamada, and Koichi Takayama. "Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review." Journal of Clinical Medicine 9, no. 5 (May 6, 2020): 1362. http://dx.doi.org/10.3390/jcm9051362.
Повний текст джерелаXiao, Gang, Zhiyuan Liu, Xuan Gao, Han Wang, Haiqin Peng, Jiahui Li, Lei Yang, Hexin Duan, and Rongrong Zhou. "Immune checkpoint inhibitors for brain metastases in non-small-cell lung cancer: from rationale to clinical application." Immunotherapy 13, no. 12 (August 2021): 1031–51. http://dx.doi.org/10.2217/imt-2020-0262.
Повний текст джерелаLopez-Beltran, Antonio, Alessia Cimadamore, Ana Blanca, Francesco Massari, Nuno Vau, Marina Scarpelli, Liang Cheng, and Rodolfo Montironi. "Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer." Cancers 13, no. 1 (January 3, 2021): 131. http://dx.doi.org/10.3390/cancers13010131.
Повний текст джерелаAlkharabsheh, Omar, Zachary Trisel, Sunil Badami, Mohammed A. Aljama, and M. Hasib Sidiqi. "Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises." Cancers 14, no. 1 (December 27, 2021): 113. http://dx.doi.org/10.3390/cancers14010113.
Повний текст джерелаAndo, Hiroyuki, Kunihiro Suzuki, and Toyoshi Yanagihara. "Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis." Biomedicines 9, no. 10 (October 16, 2021): 1484. http://dx.doi.org/10.3390/biomedicines9101484.
Повний текст джерелаHarris, Kevin B., Pauline Funchain, and Brian B. Baggott. "CMV coinfection in treatment refractory immune checkpoint inhibitor colitis." BMJ Case Reports 13, no. 5 (May 2020): e233519. http://dx.doi.org/10.1136/bcr-2019-233519.
Повний текст джерелаMarini, Alessandro, Andrea Bernardini, Gian Luigi Gigli, Mariarosaria Valente, Sergio Muñiz-Castrillo, Jérôme Honnorat, and Alberto Vogrig. "Neurologic Adverse Events of Immune Checkpoint Inhibitors." Neurology 96, no. 16 (March 2, 2021): 754–66. http://dx.doi.org/10.1212/wnl.0000000000011795.
Повний текст джерелаSchmidt, Laura, Brian McGuire, Wendy Hui, George W. Carro, Thomas A. Hensing, Daniel H. Shevrin, Nicholas Paul Campbell, Britt Erika Hanson, and Bruce Brockstein. "Immune checkpoint inhibitor toxicity in the clinical practice setting." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e14128-e14128. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14128.
Повний текст джерелаShek, Dmitrii, Scott A. Read, Liia Akhuba, Liang Qiao, Bo Gao, Adnan Nagrial, Matteo S. Carlino, and Golo Ahlenstiel. "Non-coding RNA and immune-checkpoint inhibitors: friends or foes?" Immunotherapy 12, no. 7 (May 2020): 513–29. http://dx.doi.org/10.2217/imt-2019-0204.
Повний текст джерелаÖzdemir, Berna C. "Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology." Journal for ImmunoTherapy of Cancer 9, no. 2 (February 2021): e002220. http://dx.doi.org/10.1136/jitc-2020-002220.
Повний текст джерелаKarasarides, Maria, Alexandria P. Cogdill, Paul B. Robbins, Michaela Bowden, Elizabeth M. Burton, Lisa H. Butterfield, Alessandra Cesano, et al. "Hallmarks of Resistance to Immune-Checkpoint Inhibitors." Cancer Immunology Research 10, no. 4 (March 14, 2022): 372–83. http://dx.doi.org/10.1158/2326-6066.cir-20-0586.
Повний текст джерелаDe Keukeleire, Stijn J., Tijl Vermassen, Zahra M. Nezhad, Tessa Kerre, Vibeke Kruse, Hans Van Vlierberghe, Karim Vermaelen, and Sylvie Rottey. "Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk?" Immunotherapy 13, no. 5 (April 2021): 409–18. http://dx.doi.org/10.2217/imt-2020-0273.
Повний текст джерелаAn, Ho Jung, Hong Jae Chon, and Chan Kim. "Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors." International Journal of Molecular Sciences 22, no. 17 (August 30, 2021): 9414. http://dx.doi.org/10.3390/ijms22179414.
Повний текст джерелаPandey, Pratibha, Fahad Khan, Huda A. Qari, Tarun Kumar Upadhyay, Abdulhameed F. Alkhateeb, and Mohammad Oves. "Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4." Pharmaceuticals 15, no. 3 (March 9, 2022): 335. http://dx.doi.org/10.3390/ph15030335.
Повний текст джерелаRemon, Jordi, Francesco Facchinetti, and Benjamin Besse. "The efficacy of immune checkpoint inhibitors in thoracic malignancies." European Respiratory Review 30, no. 162 (October 5, 2021): 200387. http://dx.doi.org/10.1183/16000617.0387-2020.
Повний текст джерелаMelissaropoulos, Konstantinos, Kalliopi Klavdianou, Alexandra Filippopoulou, Fotini Kalofonou, Haralabos Kalofonos, and Dimitrios Daoussis. "Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors." International Journal of Molecular Sciences 21, no. 9 (May 11, 2020): 3389. http://dx.doi.org/10.3390/ijms21093389.
Повний текст джерелаVilariño, Noelia, Jordi Bruna, Foteini Kalofonou, Garifallia G. Anastopoulou, and Andreas A. Argyriou. "Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors." International Journal of Molecular Sciences 21, no. 16 (August 11, 2020): 5774. http://dx.doi.org/10.3390/ijms21165774.
Повний текст джерелаSchmerling, Rafael A., Antonio C. Buzaid, Carolina K. Haddad, Fabio AB Schutz, Fabio R. Kater, Juliana Pimenta, Fernando Maluf, et al. "Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature review." Future Science OA 7, no. 1 (January 2021): FSO655. http://dx.doi.org/10.2144/fsoa-2020-0129.
Повний текст джерелаMenshikova, I. V., and V. V. Strogonova. "Immune-mediated adverse rheumatic reactions following administration of immune checkpoint inhibitors." Rheumatology Science and Practice 58, no. 4 (September 4, 2020): 443–46. http://dx.doi.org/10.47360/1995-4484-2020-443-446.
Повний текст джерелаHwang, June Kyu, JinWoo Hong, and Chae-Ok Yun. "Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials." International Journal of Molecular Sciences 21, no. 22 (November 16, 2020): 8627. http://dx.doi.org/10.3390/ijms21228627.
Повний текст джерела